Edition:
United States

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,216.00GBp
17 Jan 2017
Change (% chg)

-21.00p (-1.70%)
Prev Close
1,237.00p
Open
1,232.00p
Day's High
1,236.00p
Day's Low
1,215.00p
Volume
2,917,810
Avg. Vol
3,378,260
52-wk High
1,324.00p
52-wk Low
1,040.36p

SN.L

Chart for SN.L

About

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and... (more)

Overall

Beta: 0.71
Market Cap(Mil.): £10,954.36
Shares Outstanding(Mil.): 875.89
Dividend: 10.08
Yield (%): --

Financials

  SN.L Industry Sector
P/E (TTM): 37.96 34.38 30.76
EPS (TTM): 0.33 -- --
ROI: 5.86 13.26 14.82
ROE: 8.91 16.85 16.24

Fund manager laggards to be dropped from governance list

LONDON, Nov 14 Fund managers in Britain will be ranked by how they compare on corporate governance and those who do not stick to the standards set by the country's watchdog will be struck off its list.

Nov 14 2016

UPDATE 1-Smith & Nephew revenue up 2 pct, at bottom end of forecasts

LONDON, Nov 3 Artificial hip and knee maker Smith & Nephew reported a 2 percent rise in underlying quarterly revenue to $1.12 billion, towards the bottom of forecasts, after sales grew only 2 percent in the United States and stalled in other established markets.

Nov 03 2016

Smith & Nephew Q3 revenue rise at bottom-end of forecasts

LONDON, Nov 3 Artificial hip and knee maker Smith & Nephew reported a 2 percent rise in third-quarter revenue to $1.12 billion, towards the bottom of expectations, as sales grew only 2 percent in the United States and stalled in other established markets.

Nov 03 2016

Investor warns Britain's top firms not to ignore pay revolts

LONDON, Sept 16 Britain's top companies need to cut bonuses in response to shareholder revolts against senior executives' pay, the fund arm of insurer Legal & General said in a letter to the top 350 firms.

Sep 16 2016

Investor warns Britain's top firms not to ignore pay revolts

LONDON Britain's top companies need to cut bonuses in response to shareholder revolts against senior executives' pay, the fund arm of insurer Legal & General said in a letter to the top 350 firms in the UK.

Sep 16 2016

BRIEF-Smith & Nephew starts share buyback after gynaecology divestment completes

* Smith & nephew completes gynaecology sale and commences $300 million share buy-back programme

Aug 08 2016

FTSE edges down from 1-year high, earnings weigh

* AstraZeneca closes at a record high (Adds detail and updates prices at close)

Jul 28 2016

FTSE edges down from 1-year high, earnings weigh

LONDON, July 28 Britain's top share index dipped on Thursday after hitting a one-year high in the previous session, with Smith & Nephew and Royal Dutch Shell falling after poorly received trading updates.

Jul 28 2016

Smith & Nephew buoyed by sports medicine but China weak

LONDON, July 28 Smith & Nephew, Europe's biggest maker of artificial knees and hips, reported a 2 percent rise in second-quarter revenue on Thursday, helped by good growth in its sports medicine joint repair business.

Jul 28 2016

Earnings vs. Estimates